Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Decrease of Aggregation By Platelet Impedance Aggregometry ( MULTIPLATE ) in Patients Treated with Dabigatran

Valentin Cabañas, Juan Jose Cerezo-Manchado, MD PhD, Faustino Garcia-Candel, MD PhD, Eduardo Salido, MD PhD, Raul Lopez-Perez, MD PhD, Ana Garcia-Hernandez, MD PhD, Merecedes Berenguer, MD PhD, Francesca Labbadia, MD, Miguel Blanquer Blanquer, MD PhD, Jose Maria Moraleda, MD PhD

Blood (2016) 128 (22): 5022.

https://doi.org/10.1182/blood.V128.22.5022.5022

Published: 2016

Journal Articles

How Are Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS) Treated? Impact on Clinical Evolution and Overall Survival: A Report from the Erasme Study

Julia Montoro, MD, Helena Pomares, MD, Itziar Oiartzabal, MD, Teresa Bernal, MD, Edgardo Barranco, MD, Rosa Coll, MD, Rafael Romero, MD, Marisa Calabuig, MD, Eduardo Salido, MD PhD, Marta Castellanos, MD, Angeles Medina, MD, Gemma Azaceta, MD PhD, Mireya Navarro, MD, Silvia López, David Valcárcel, MD PhD

Blood (2015) 126 (23): 5239.

https://doi.org/10.1182/blood.V126.23.5239.5239

Published: 2015

Journal Articles

Clinical Significance of Myelofibrotic (MF) Changes in Myelodysplastic Syndromes (MDS): A Prospective Evaluation Including Mutational Analysis By Next-Generation Sequencing (NGS)

Fernando Ramos, MDPhDMPH, Cristina Robledo, PhD, Francisco Miguel Izquierdo-García, MDPhD, Dimas Suárez-Vilela, MDPhD, Rocío Benito, PhD, Marta Fuertes, MDPhD, Andrés Insunza, MD, Eva Barragan, PhD, Mónica del Rey, PhD, José María García-Ruiz de Morales, MDPhD, Mar Tormo, MDPhD, Eduardo Salido, MDPhD, Lurdes Zamora, PhD, Carmen Pedro, MD, Javier Sánchez-del-Real, MD, María Díez-Campelo, MD PhD, Consuelo del Cañizo, MD PhD, Guillermo F. Sanz, MD PhD, Jesus Maria Hernández-Rivas, MDPhD

Blood (2014) 124 (21): 4652.

https://doi.org/10.1182/blood.V124.21.4652.4652

Published: 2014

Journal Articles

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Fernando Ramos, MD, PhD, MPH, Carmen Pedro, Jose-Maria Garcia-Ruiz-de-Morales, Eva Barragan, Raquel de Paz, Andres Insunza, Mar Tormo, Maria Diez-Campelo, Blanca Xicoy, Eduardo Salido, Javier Sanchez-del-Real, Leonor Arenillas, Carlos Santamaria, Noemi Puig, Lourdes Florensa, Francesc Sole, Marcos González, Elisa Luño, Guillermo F Sanz

Blood (2012) 120 (21): 3803.

https://doi.org/10.1182/blood.V120.21.3803.3803

Published: 2012

Journal Articles

Study of the Relationship of Product Infused with Survival in Patients with Hodgkin’s Disease and No Hodgkin’s Lymphoma Undergoing Autologus Stem Cell Transplantation

Eduardo Salido, Maria Juliana Majado, Alfredo Minguela, Jose Maria Moraleda, Consuelo Gonzalez, Antonio Parrado, Consuelo Funes, Maria Victoria Martinez-Sanchez, Alfonso Morales

Blood (2008) 112 (11): 4443.

https://doi.org/10.1182/blood.V112.11.4443.4443

Published: 2008

Journal Articles

Megakaryocytic Progenitors in Long Term Cultures from MDS Patients.

Maria Juliana Majado, MD, María I. Macizo, MD, Consuelo González-García, MD, Eduardo Salido, MD, José A. Molina, MD, Jorge Monserrat, MD, Alfonso Morales, MD

Blood (2005) 106 (11): 4924.

https://doi.org/10.1182/blood.V106.11.4924.4924

Published: 2005

NARROW

Decrease of Aggregation By Platelet Impedance Aggregometry ( MULTIPLATE ) in Patients Treated with Dabigatran

How Are Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS) Treated? Impact on Clinical Evolution and Overall Survival: A Report from the Erasme Study

Clinical Significance of Myelofibrotic (MF) Changes in Myelodysplastic Syndromes (MDS): A Prospective Evaluation Including Mutational Analysis By Next-Generation Sequencing (NGS)

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Study of the Relationship of Product Infused with Survival in Patients with Hodgkin’s Disease and No Hodgkin’s Lymphoma Undergoing Autologus Stem Cell Transplantation

Megakaryocytic Progenitors in Long Term Cultures from MDS Patients.

Email alerts

ASH Publications

American Society of Hematology

Decrease of Aggregation By Platelet Impedance Aggregometry ( MULTIPLATE ) in Patients Treated with Dabigatran

How Are Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS) Treated? Impact on Clinical Evolution and Overall Survival: A Report from the Erasme Study

Clinical Significance of Myelofibrotic (MF) Changes in Myelodysplastic Syndromes (MDS): A Prospective Evaluation Including Mutational Analysis By Next-Generation Sequencing (NGS)

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Study of the Relationship of Product Infused with Survival in Patients with Hodgkin’s Disease and No Hodgkin’s Lymphoma Undergoing Autologus Stem Cell Transplantation

Megakaryocytic Progenitors in Long Term Cultures from MDS Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only